Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • adnancho
    Junior Member
    • Jul 2015
    • 1

    Newbie Question on sample size

    Hi I'm trying to bring RNA-seq into our lab. Our samples will be variable +/-1000 cells, 3-4000 cells total. After I lyse the cells for RNA, should I run the entire sample or should I get the concentration of RNA and use a specific total RNA amount for making each library? How do you adjust for between sample variability and for that matter within sample variability? Or does this come out in the wash during normalization of the data?

    Thank you.
  • nucacidhunter
    Jafar Jabbari
    • Jan 2013
    • 1250

    #2
    Amount of RNA for library prep would be based on recommendations by the kit manufacturer and varies from kit to kit.

    Comment

    • AllSeq
      Registered Vendor
      • Oct 2013
      • 138

      #3
      That level of variability will 'come out in the wash' long before you get to generating data. Even if you start with variable amounts of input RNA, you'll aim for putting equivalent amounts of library DNA onto the flow cell. As long as you have enough input RNA for the kit, you should be ok. That said, kits often will produce different results with different starting amounts - you'll start seeing noisier data as you push towards the lower limits of what the kit can handle.
      AllSeq - The Sequencing Marketplace
      [email protected]
      www.AllSeq.com

      Comment

      Latest Articles

      Collapse

      • mylaser
        Reply to Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by mylaser
        Kheloyar – Everything You Need to Know About Kheloyaar Login and Kheoyar Id
        If you are looking for an online gaming platform that offers a user-friendly experience, Kheloyar has become a name that many users search for. Whether you're interested in creating a new account, accessing your dashboard through Kheloyaar Login, or learning how to obtain a Kheoyar Id, understanding the platform's features and account process is essential.
        This guide explains everything you need to know about...
        Yesterday, 01:13 AM
      • SEQadmin2
        Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
        by SEQadmin2



        Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
        ...
        07-09-2026, 11:10 AM
      • SEQadmin2
        Cancer Drug Resistance: The Lingering Barrier to Rising Survival
        by SEQadmin2



        Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

        There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
        07-08-2026, 05:17 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, 07-09-2026, 10:04 AM
      0 responses
      22 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-08-2026, 10:08 AM
      0 responses
      14 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-07-2026, 11:05 AM
      0 responses
      32 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 07-02-2026, 11:08 AM
      0 responses
      31 views
      0 reactions
      Last Post SEQadmin2  
      Working...